Skip to main content

Table 2 Initial DTC stage and response to treatment of acromegalic patients

From: Acromegaly and thyroid cancer: analysis of evolution in a series of patients

Stage

I

19/24 (79%)

 II

4/24 (17%)

 IVb

1/24 (4%)

Initial RR

Low

21/24 (87%)

 Intermediate

2/24 (9%)

 High

1/24 (4%)

Initial response

Excellent

12/23 (52%)

 Indeterminate

7/23 (31%)

 Biochemical incomplete

3/23 (13%)

 Structural incomplete

1/23 (4%)

RFU

No evidence of disease

19/23 (83%)

 Indeterminate

2/23 (9%)

 Biochemical incomplete

1/23 (4%)

 Structural incomplete

1/23 (4%)

  1. RR recurrence risk, RFU response at the end of follow-up